1-7 of 7
Yan Li
Close
Sort by
Journal Articles

A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2 -mutant AML

Clinical Trials & Observations
Sheng F. Cai, Ying Huang, Jennie R. Lance, Hsiaoyin Charlene Mao, Andrew J. Dunbar, Samantha N. McNulty, Todd Druley, Yan Li, Maria R. Baer, Wendy Stock, Tibor Kovacsovics, William G. Blum, Gary J. Schiller, Rebecca L. Olin, James M. Foran, Mark Litzow, Tara Lin, Prapti Patel, Matthew C. Foster, Michael Boyiadzis, Robert H. Collins, Jordan Chervin, Abigail Shoben, Jo-Anne Vergilio, Nyla A. Heerema, Leonard Rosenberg, Timothy L. Chen, Ashley O. Yocum, Franchesca Druggan, Sonja Marcus, Mona Stefanos, Brian J. Druker, Alice S. Mims, Uma Borate, Amy Burd, John C. Byrd, Ross L. Levine, Eytan M. Stein
Journal: Blood Advances
Blood Adv (2024) 8 (2): 429–440.
https://doi.org/10.1182/bloodadvances.2023010563
Published: 2024
Includes: Supplemental data
Journal Articles

Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study

Clinical Trials & Observations
Li-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, Ming-Zhi Zhang, Zhi-Ming Li, Chun-Yan Ji, Wei Xu, Ting Liu, Bing Xu, Xin Wang, Su-Jun Gao, Hui-Lai Zhang, Yu Hu, Yan Li, Ying Cheng, Hai-Yan Yang, Jun-Ning Cao, Zun-Min Zhu, Jian-Da Hu, Wei Zhang, Hong-Mei Jing, Kai-Yang Ding, Xiang-Yang Zhang, Ren-Bin Zhao, Bin Zhang, Ya-Min Tian, Yong-Ping Song, Yu-Qin Song, Jun Zhu
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4349–4357.
https://doi.org/10.1182/bloodadvances.2022009168
Published: 2023
Includes: Supplemental data
Journal Articles

Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2

Wenjun Wu, Weige Wang, Carrie A. Franzen, Hui Guo, Jimmy Lee, Yan Li, Madina Sukhanova, Dong Sheng, Girish Venkataraman, Mei Ming, Pin Lu, Anhui Gao, Chunmei Xia, Jia Li, Liang Leo Zhang, Vivian Changying Jiang, Michael L. Wang, Jorge Andrade, Xiaoyan Zhou, Y. Lynn Wang
Journal: Blood Advances
Blood Adv (2021) 5 (1): 185–197.
https://doi.org/10.1182/bloodadvances.2020001665
Published: 2021
Includes: Supplemental data
Journal Articles

Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma

Jimmy Lee, Liang Leo Zhang, Wenjun Wu, Hui Guo, Yan Li, Madina Sukhanova, Girish Venkataraman, Shengjian Huang, Hui Zhang, Mir Alikhan, Pin Lu, Ailin Guo, Natalie Galanina, Jorge Andrade, Michael L. Wang, Y. Lynn Wang
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2039–2051.
https://doi.org/10.1182/bloodadvances.2018016048
Published: 2018
Includes: Supplemental data
Journal Articles

The characteristics of vessel lining cells in normal spleens and their role in the pathobiology of myelofibrosis

Jiajing Qiu, Mohamed E. Salama, Cing Siang Hu, Yan Li, Xiaoli Wang, Ronald Hoffman
Journal: Blood Advances
Blood Adv (2018) 2 (10): 1130–1145.
https://doi.org/10.1182/bloodadvances.2017015073
Published: 2018
Includes: Supplemental data
Journal Articles

Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy

Clinical Trials & Observations
Zimu Gong, L. Jeffrey Medeiros, Jorge E. Cortes, Zi Chen, Lan Zheng, Yan Li, Shi Bai, Pei Lin, Roberto N. Miranda, Jeffrey L. Jorgensen, Timothy J. McDonnell, Wei Wang, Hagop M. Kantarjian, Shimin Hu
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2541–2552.
https://doi.org/10.1182/bloodadvances.2017011858
Published: 2017
Includes: Supplemental data
Journal Articles

A functional DC cross talk promotes human ILC homeostasis in humanized mice

Silvia Lopez-Lastra, Guillemette Masse-Ranson, Oriane Fiquet, Sylvie Darche, Nicolas Serafini, Yan Li, Mathilde Dusséaux, Helene Strick-Marchand, James P. Di Santo
Journal: Blood Advances
Blood Adv (2017) 1 (10): 601–614.
https://doi.org/10.1182/bloodadvances.2017004358
Published: 2017
Includes: Supplemental data